Showing results (621-630 of 677) with videos related to
Sort By:
Pageof 68
Acta Crystallographica. Section B, Structural Science|January 22, 2008
Patterns of hydrogen bonding in mono- and di-substituted N-arylpyrazinecarboxamidesSolange M S V Wardell, Marcus V N de Souza, Thatyana R A Vasconcelos, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1984
Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemiaJ H Rowland, O J Glidewell, R F Sibley, et al.Human Biology|December 29, 2000
Phylogenetic relationships of human populations in sub-Saharan AfricaW Weber, D J Nash, A G Motulsky, et al.Plos One|November 2, 2018
How do hospitals respond to feedback about blood transfusion practice? A multiple case study investigationNatalie J Gould, Fabiana Lorencatto, Camilla During, et al.Cancer|May 1, 1978
Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin's disease, lymphosarcoma nad reticulum cell sarcomaP Maurice, O Glidewell, C Jacquillat, et al.Implementation Science : IS|January 28, 2022
Explaining variable effects of an adaptable implementation package to promote evidence-based practice in primary care: a longitudinal process evaluationLiz Glidewell, Cheryl Hunter, Vicky Ward, et al.Acta Crystallographica. Section B, Structural Science|September 28, 2000
N-(6-Amino-3,4-dihydro-3-methyl-5-nitroso-4-oxopyrimidin-2-yl) derivatives of glycine, valine, serine, threonine and methionine: interplay of molecular, molecular-electronic and supramolecular structuresJ N Low, M D López, P Arranz Mascarós, et al.American Journal of Clinical Oncology|June 1, 1984
A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer. A Cancer and Leukemia Group B studyD C Tormey, V E Weinberg, L A Leone, et al.Chemosphere|May 6, 2003
Waterborne and sediment toxicity of fluoxetine to select organismsBryan W Brooks, Philip K Turner, Jacob K Stanley, et al.Cancer|February 1, 1975
Comparison of the combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and vincristine with two dose schedules of 5-(3,3-dimethyl-1-triazino) imidazole 4-carboxamide (DTIC) in the treatment of disseminated malignant melanomaJ H Moon, S Gailani, M R Cooper, et al.Pageof 68